Needle in a haystack: identifying drivers of malignant transformation in neurofibromas
Neuro Oncol
.
2019 Aug 5;21(8):961-962.
doi: 10.1093/neuonc/noz086.
Authors
Suganth Suppiah
1
2
,
Kenneth Aldape
2
3
,
Gelareh Zadeh
2
4
5
Affiliations
1
Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
2
MacFeeters-Hamilton Centre for Neuro-Oncology Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
3
Laboratory of Pathology, Centre for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
4
Division of Neurosurgery, University Health Network, Toronto, Ontario, Canada.
5
Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
PMID:
31099395
PMCID:
PMC6682205
DOI:
10.1093/neuonc/noz086
No abstract available
Publication types
Comment
MeSH terms
Humans
Mutation
Nerve Sheath Neoplasms*
Neurofibroma* / epidemiology
Neurofibromatoses*
Neurofibromatosis 1*
Transcription Factors
Substances
SMARCA2 protein, human
Transcription Factors